Hydroxyethylstarches: Discussion, clarity and traceability;Hydroxyéthylamidons : discuter, clarifier et tracer

Annales Francaises d'Anesthesie et de Reanimation

Volumn 28, Issue 7-8, 2009, Pages 706-707

  Mion, G ^a   Libert, N ^a   de Rudnicki, S ^b   Cirodde, A ^a   Leclerc, T ^b  

^a Ecole du Val de Grace   (France)

^b University of Paris Descartes   (France)

Author keywords

Hydroxyethylstarch; Renal function; Severe sepsis; Shock

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH; PLASMA SUBSTITUTE;

ANESTHESIA INDUCTION; FLUID RESUSCITATION; HEART SURGERY; HUMAN; KIDNEY FUNCTION; KIDNEY PERFUSION; LETTER; PERIOPERATIVE PERIOD; RISK ASSESSMENT; SEPSIS; SHOCK; AGED; NOTE; RESUSCITATION; SEPTIC SHOCK;

AGED; HETASTARCH; HUMANS; PLASMA SUBSTITUTES; RESUSCITATION; SHOCK, SEPTIC;

EID: 68449090522     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2009.06.018     Document Type: Letter

References (11)

1. Mimoz O, Capdevila X, pour le comité scientifique et le comité réanimation de la Sfar. Faut-il ne plus prescrire d'hydroxyéthylamidon (HEA). Ann Fr Anesth Reanim 2009;28 [doi:10.16/j.annfar.2009.04.006].
2. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 (2008) 125-139
3. Brochard L., Schortgen F., Brun-Buisson C., Dreyffuss D., Rouby J.J., Chastre J., et al. Pour un moratoire sur l'utilisation des hydroxyéthylamidons. Reanimation 17 (2008) 588-591
4. Schortgen F., Lacherade J.C., Bruneel F., Cattaneo I., Hemery F., Lemaire F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357 (2001) 911-916
5. Schortgen F., Girou E., Deye N., Brochard L., and for the CRYCO Study Group. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34 (2008) 2157-2168
6. Mion G., Libert N., and Cirodde A. Hydroxy-ethyl-starches: are the conclusions always evidence-based?. Intensive Care Med 35 (2009) 1147
7. Jacob M., Chappell D., Conzen P., Wilkes M.M., Becker B.F., and Rehm M. Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care 12 (2008) R34
8. Sirtl C., Laubenthal H., Zumtobel V., Kraft D., and Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82 (1999) 510-515
9. Chappell D., Jacob M., Hofmann-Kiefer K., Conzen P., and Rehm M. A rational approach to perioperative fluid management. Anesthesiology 109 (2008) 723-740
10. Huter L., Simon T.P., Weinmann L., Schuerholz T., Reinhart K., Wolf G., et al. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 13 (2009) R23
11. Boldt J., Brosch Ch, Röhm K., Papsdorf M., and Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 100 (2008) 457-464